GlaxoSmithKline Pharmaceuticals Limited documents

Explore the latest documents from GlaxoSmithKline Pharmaceuticals Limited, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Description

Event date

Documents and forms

2026

Q1 25/26

Aug 1, 2025

Slides

Interim report

2025

Q4 24/25

May 13, 2025

Slides

Transcript

Interim report

Q3 24/25

Feb 14, 2025

Slides

Interim report

Q2 24/25

Oct 28, 2024

Interim report

Q1 24/25

Aug 2, 2024

Interim report

2024

Status Update

Aug 5, 2024

Slides

Q4 23/24

May 17, 2024

Interim report

Q3 23/24

Feb 12, 2024

Interim report

Q2 23/24

Nov 9, 2023

Report

Q1 23/24

Jul 26, 2023

Interim report

2023

Q4 22/23

May 17, 2023

Report

Status Update

Mar 16, 2023

Slides

Q3 22/23

Feb 7, 2023

Report

Q2 22/23

Nov 11, 2022

Interim report

Q1 22/23

Jul 25, 2022

Interim report

2022

Status Update

Aug 23, 2022

Slides

Q4 21/22

May 16, 2022

Interim report

Q3 21/22

Feb 6, 2022

Interim report

Q2 21/22

Oct 29, 2021

Report

Q1 21/22

Jul 25, 2021

Interim report